Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis-Reference-Cited by-同舟云学术

Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis

Published:2016 Issue:13 Volume:55 Page:1721-1727
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yamamoto Wataru¹,Andou Taiki¹,Itabashi Megumi¹,Koyama Satoshi¹,Ishii Yoshimi¹,Numata Ayumi¹,Motohashi Kenji¹,Hagihara Maki¹,Matsumoto Kenji¹,Fujisawa Shin¹

Affiliation:

1. Department of Hematology, Yokohama City University Medical Center, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/55/13/55_55.6094/_pdf

Reference18 articles.

1. 1. Deeg HJ, Sandmaier BM. Who is fit for allogeneic transplantation? Blood 116: 4762-4770, 2010.

2. 2. Terakura S, Atsuta Y, Sawa M, et al. A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies. Ann Oncol 22: 1865-1871, 2011.

3. 3. Chen YB, Coughlin E, Kennedy KF, et al. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia. Biol Blood Marrow Transplant 19: 981-987, 2013.

4. 4. Parmar S, Rondon G, de Lima M, et al. Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized study. Biol Blood Marrow Transplant 19: 474-480, 2013.

5. 5. Lee SE, Kim HJ, Min WS, et al. Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities. Int J Hematol 92: 342-350, 2010.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes;Transplantation and Cellular Therapy;2021-11

2. Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia;Leukemia & Lymphoma;2020-03-05